المؤلفون: Singh RP, Silva FQ, Gibson A, Thompson D, Vitti R, Berliner AJ, Saroj N

المصدر: Ophthalmic surgery, lasers & imaging retina [Ophthalmic Surg Lasers Imaging Retina] 2019 Mar 01; Vol. 50 (3), pp. 167-173.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Healio.com Country of Publication: United States NLM ID: 101599215 Publication Model: Print Cited Medium: Internet ISSN: 2325-8179 (Electronic) Linking ISSN: 23258160 NLM ISO Abbreviation: Ophthalmic Surg Lasers Imaging Retina Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors/*therapeutic use , Diabetic Retinopathy/*drug therapy , Laser Coagulation/*methods , Macular Edema/*drug therapy , Receptors, Vascular Endothelial Growth Factor/*therapeutic use , Recombinant Fusion Proteins/*therapeutic use, Aged ; Aged, 80 and over ; Female ; Humans ; Intravitreal Injections ; Male ; Middle Aged ; Visual Acuity

المؤلفون: Moshfeghi DM, Hariprasad SM, Marx JL, Thompson D, Soo Y, Gibson A, Saroj N, Vitti R, Heier JS

المصدر: Ophthalmic surgery, lasers & imaging retina [Ophthalmic Surg Lasers Imaging Retina] 2016 Mar; Vol. 47 (3), pp. 238-44.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Healio.com Country of Publication: United States NLM ID: 101599215 Publication Model: Print Cited Medium: Internet ISSN: 2325-8179 (Electronic) Linking ISSN: 23258160 NLM ISO Abbreviation: Ophthalmic Surg Lasers Imaging Retina Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors/*therapeutic use , Ranibizumab/*therapeutic use , Receptors, Vascular Endothelial Growth Factor/*therapeutic use , Recombinant Fusion Proteins/*therapeutic use , Subretinal Fluid/*drug effects , Wet Macular Degeneration/*drug therapy, Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/adverse effects ; Double-Blind Method ; Drug Combinations ; Female ; Follow-Up Studies ; Humans ; Intravitreal Injections ; Male ; Ranibizumab/adverse effects ; Recombinant Fusion Proteins/adverse effects ; Retina/pathology ; Subretinal Fluid/physiology ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Visual Acuity/physiology ; Wet Macular Degeneration/physiopathology